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Abstract For over a century, the importance of lipid
metabolism in biology was recognized but difficult to
mechanistically understand due to the lack of sensitive and robust technologies for identification and
quantification of lipid molecular species. The
enabling technological breakthroughs emerged in the
1980s with the development of soft ionization
methods (Electrospray Ionization and Matrix Assisted
Laser Desorption/Ionization) that could identify and
quantify intact individual lipid molecular species.
These soft ionization technologies laid the foundations for what was to be later named the field of
lipidomics. Further innovative advances in multistage
fragmentation, dramatic improvements in resolution
and mass accuracy, and multiplexed sample analysis
fueled the early growth of lipidomics through the
early 1990s. The field exponentially grew through the
use of a variety of strategic approaches, which
included direct infusion, chromatographic separation, and charge-switch derivatization, which facilitated access to the low abundance species of the
In this Thematic Review, we provide a
lipidome.
broad perspective of the foundations, enabling advances, and predicted future directions of growth of
the lipidomics field.
Supplementary key words lipids • lipid metabolism • mass
spectrometry • soft ionization • electrospray ionization • matrixassisted laser desorption/ionization • shotgun lipidomics •
chromatographic separation • charge-switch derivatization

COMPLEXITY OF LIPID BIOCHEMISTRY
Cellular lipids are comprised of a plethora of unique
structures that contain many hundreds of thousands
(or more) distinct lipid molecular species (1). Historically, lipids have been broken down into nonpolar
lipids (e.g., triglyceride (TG) and cholesterol) and
polar lipids (choline glycerophospholipid (PC), ethanolamine glycerophospholipid (PE), inositol glycerophospholipid (PI), etc.) (2). In 2005, the LIPID MAPS
consortium published a classification scheme that
*For correspondence: Xianlin Han, hanx@uthscsa.edu.

placed individual lipid molecular species into eight
categories, including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol
lipids, and saccharolipids (1). In each category, individual lipid molecular species are further divided into
lipid classes based on their polar head groups. For
example, glycerophospholipids are grouped the classes
of PC, PE, PI, serine glycerophospholipid (PS), etc. according to their polar head groups containing phosphocholine, phosphoethanolamine, phosphoinositol,
phosphoserine, and others, respectively, linked to a
glycerol backbone (Fig. 1).
In addition, owing to the existence of some special
structural similarity or unique characters, the molecular species in an individual class can be further classified into subclasses of the class. For example, based on
the existence of different chemical bonds of the
aliphatic chain to the sn-1 glycerol hydroxy group in
glycerophospholipids, individual classes in this category
are further grouped into three specific subclasses
(Fig. 1). Specifically, the aliphatic chain at the sn-1 position of glycerol can be linked as a bond of ester, ether,
or vinyl ether moiety in individual glycerophospholipid
classes, which are termed as phosphatidyl-, plasmanyl-,
or plasmenyl-, respectively, according to the recommended nomenclature by International Union of Pure
and Applied Chemists (3). Similar subclasses of glycerolipids are also present in the classes of diglyceride (DG)
and TG (4). In addition, due to differences in the
backbone of sphingosine or sphinganine (i.e., with or
without existence of a double bond between C4 and C5
of sphingoid base), an individual sphingolipid class can
also be grouped into sphingolipid and dihydrosphingolipid subclasses.
A large number of aliphatic chains are present in
lipids varying with lengths, degrees of unsaturation,
locations of double bonds, cis-trans isomers, branched
chains, etc. These variable aliphatic chains form a large
number of individual molecular species. It can be
readily derived that a total of N3 and N4 distinct molecular species (where N is the number of different
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Fig. 1. Summary of classes, subclasses, and molecular species in glycerophospholipid. The polar moiety (X), which is connected to
the phosphate group, defines the individual class of glycerophospholipid (GPL). The linkage (i.e., ester, ether, and vinyl ether) of the
aliphatic chain to the hydroxy group at the sn-1 position of glycerol defines the structure of an individual subclass of phosphatidyl-,
plasmanyl-, or plasmenyl-, respectively. The identities at R1 and R2, which vary with different number of carbon atoms, number of
double bonds, the location of the double bonds, etc. define the individual molecular species of each lipid class.

aliphatic chains) can potentially be present in the classes
of TG (5) and cardiolipin (6), respectively. In fact,
the presence of hundreds of individual plasmenyl PE
species in mammalian organs has previously been
demonstrated (7).
Further excitement arose through the demonstration
that many factors of biological and chemical significance could influence the variations in cellular lipids,
which extended their biological effects through
altering membrane charge, dynamics, and physical
properties. For example, different organisms, cell types,
intracellular
organelles,
subcellular
membrane
compartment, and membrane microdomains (e.g., caveola and/or rafts) contain very distinct cellular lipid
molecular species and composition (8–10). These
numerous molecular species change dynamically after
perturbation of the environment, nutrient source, or
intermolecular interactions (11–14).
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The complexity of the effects of lipids on biological
processes is due, in part, to their distinct physical and
chemical properties that are enabling for essential
cellular functions (Fig. 2) (16). These include, but are
not limited to, the following: i) forming cellular membranes in biological organisms and organelles to provide hydrophobic barriers to separate cellular
compartments and establish membrane potentials; ii)
dynamically modulating cellular membrane physical
properties to provide necessary matrices to regulate the
activity of transmembrane proteins; iii) serving as intraand extra-cellular lipid second messengers during
signal transduction; iv) providing energy storage depots
for cellular metabolism used in many biological processes; and v) anchoring many proteins binding to the
cellular surface and membranes. Numerous studies
demonstrated that, in addition to the lysosomal storage
diseases (17), aberration of lipid metabolism and

Fig. 2. The pleiotropic roles of lipids in cellular functions. Lipids fulfill multiple roles in cellular function including cellular
signaling (top left) through the following: i) harboring latent second messengers of signal transduction that are released by phospholipases; ii) covalent transformation of membrane lipids into biologically active ligands by kinases (e.g., PI 3,4,5-triphosphate); iii)
providing molecular scaffolds for the assembly of protein complexes mediating receptor/effector coupling (e.g., G protein-coupled
receptors); and iv) coupling the vibrational, rotational, and translational energies and dynamics of membrane lipids to transmembrane proteins such as ion channels and transporters (top right), thereby facilitating dynamic cooperative lipid-protein interactions that collectively regulate transmembrane protein function. Moreover, lipids play essential roles in mitochondrial cellular
bioenergetics (bottom) through the use of fatty acids as substrates for mitochondrial β-oxidation (bottom left) that result in the
production of reducing equivalents (e.g., NADH). The chemical energy in NADH is harvested through oxidative phosphorylation
whose flux is tightly regulated by mitochondrial membrane constituents including cardiolipins, which modulate electron transport
chain (ETC) supercomplex formation. A second mechanism modulating mitochondrial energy production is the dissipation of the
proton gradient by the transmembrane flip-flop of fatty acids in the mitochondrial inner membrane bilayer and the fatty acidmediated regulation of uncoupling proteins (UCP). Reprinted with permission from ref. (15). Copyright 2011 Elsevier Ltd.

homeostasis is associated with many human diseases
(e.g., diabetes and obesity, atherosclerosis and stroke,
cancer, psychiatric disorders, neurodegenerative diseases and neurological disorders, and autoimmune
disorders) (see recent reviews for references (18–25)),
clearly demonstrating that lipids play many vital roles
in human health and disease.

LIPIDOMICS AND ITS RELATIONSHIP WITH
METABOLOMICS
The majority of early studies on lipid biochemistry
focused on one molecular species, one class, or

one enzyme-mediated pathway. In those studies, researchers have clearly recognized that the metabolism
of lipid species and specific molecular classes and
subclasses is interwoven. To understand the biological
relevance of these changes demands a comprehensive
study on lipid metabolism that greatly catalyzed
the emergence of lipidomics. Those pioneering
studies on lipid homeostasis, signaling, and transport
truly demonstrated the power of lipidomic analysis
by using a variety of tools. Most importantly, those
studies also provided the initial insight into the
utility of identifying alterations in membrane structures and functions that mediate salutary biological
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responses in health and maladaptive alterations during
disease.
The term “lipidome”, which refers to the entire
collection of chemically distinct lipid molecular species
in a cell, an organ, or a biological system, first
appeared in the peer-reviewed publication in 2001 (26).
The term “functional lipidomics” was described as “the
study of the role played by membrane lipids” by
Rildfors and Lindblom in 2002 (27). In 2003, Han and
Gross outlined the scope of the research in lipidomics
discipline through incorporating multiple techniques
to “i) quantify the precise chemical constituents in a
cell’s lipidome, ii) identify their cellular organization
(subcellular membrane compartments and domains),
iii) delineate the biochemical mechanisms through
which lipids interact with each other and with crucial
membrane-associated proteins, iv) determine lipidlipid and lipid-protein conformational space and dynamics, and v) quantify alterations in lipid constituents
after cellular perturbations” in their thematic review
(11). This definition identifies lipidomics as a new field
heavily relying on the tools, technologies, and principles of analytical chemistry for the analysis of lipid
structures, abundance of discrete molecular species,
cell functions, and interactions that collectively identify the dynamic changes of lipids during cellular
perturbations. Accordingly, lipidomics plays an essential role in defining the biochemical mechanisms underlying lipid-related disease processes through
identification and quantification of alterations in
cellular lipid signaling, metabolism, trafficking, and
homeostasis.
Because lipids are cellular metabolic products, lipidomics falls under the larger umbrella of the general
field of “metabolomics”. In fact, most metabolomics
studies cover the analysis of some classes of lipids or
expand lipid analysis to a certain degree (28). However,
special physical and chemical characteristics of lipids in
contrast to most other water-soluble cellular metabolites make lipidomics a distinct discipline from general
metabolomics, as discussed below.
As previously stated, each of most lipid classes may
contain hundreds to thousands or many tens of thousands of individual lipid molecular species. This
large number of individual molecular species in a class
are formed by de novo synthesis, phospholipaseacyltransferase remodeling (e.g., glycerophospholipids)
or represent the consequence of different isoforms of
enzymatic activity (e.g., sphingolipids). From a chemical
perspective, an individual node of a metabolic network
indicates the transformation of a molecule connected
by upstream or downstream metabolites. Unfortunately, neither the content of individual lipid molecular
species nor the mass of an entire lipid class can provide
information on the flux into and out of a metabolic
node. Typically, analysis of metabolic flux requires
measurement of stable isotope labeling from pulsechase experiments. Thus, an understanding of
4
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metabolism in lipidomics is much more complex than
that in metabolomics.
In contrast to other cellular metabolites, lipid molecular species which contain at least one hydrophobic
region are extractable with some type of organic solvents to a certain degree, and their solubility is dependent on the polar water-soluble group. This physical
property makes the majority of lipids readily recovered
and largely separated from other cellular metabolites.
However, this amphiphilic structure also readily forms
aggregates even in organic solvents as the concentration of lipids increases and exceeds the ability of a
given solvent to solubilize them as monomers (16). This
physical characteristic makes quantification of intact
individual lipid molecular species difficult and inaccurate by MS under certain conditions since different
aggregates show very different ionization response
factors (29). Furthermore, the existence of a large
number of isomeric/isobaric lipid species in cellular
lipidomes makes very challenging and special in comparison to metabolomics.

THE HISTORY OF LIPIDOMICS DEVELOPMENT
Classical lipid analysis with a variety of analytical
techniques
In the history of lipid analysis, many tools including
gas chromatography (GC), HPLC, TLC, MS with
different types of ion sources (e.g., electron ionization,
chemical ionization, field desorption, thermal desorption, etc.), nuclear magnetic resonance, spectroscopic
techniques, etc. have all been used for lipid analysis
alone or coupled each other (2, 30, 31). Each of these
techniques played important roles historically in elucidating lipid structures, identifying new lipids, and
quantifying lipid abundance with appropriate internal
standard(s) and with noted limitations (32, 33).
With the development of fast atom bombardmentMS and later atmospheric pressure chemical
ionization-MS coupled with HPLC (online or offline),
analysis of intact lipid molecular species became
possible (34–41) without interfering amounts of insource fragmentation. Using these techniques, classspecific analysis of individual molecular species was
also practically performed with neutral loss or precursor ion monitoring of polar head groups (36).
Remarkably, a prototype of functional lipidomics was
demonstrated through profiling intact phospholipid
molecular species. In brief, Gross exploited the power
of HPLC and fast atom bombardment-MS and identified plasmalogens as the major phospholipid constituents of sarcolemma (34), sarcoplasmic reticulum, and
their presence in mitochondrial membranes (35) of
canine ventricular myocardium. Those studies demonstrated that arachidonic acid was highly enriched in
plasmalogen molecular species in sarcolemma and
sarcoplasmic reticulum. Because the release of

arachidonic acid from their storage depots is the ratelimiting step in signal transduction in eicosanoid
cascade, the aforementioned findings presaged the
identification of plasmalogen-selective phospholipases
in the release of arachidonic acid from plasmalogen
species (42–44). Furthermore, through the use of specifically labeled diacyl and plasmalogen molecular
species markedly differential molecular dynamics and
averaged conformational states were identified for
plasmalogens in comparison to their diacyl counterparts (45–50).
Prelipidomics era (before 2003) by ESI-MS and
MALDI-MS analysis
Analysis of intact cellular lipids was greatly accelerated with the advances in ionization technologies,
which was in large part fueled by the development of
ESI and MALDI by Nobel Laureates, John Fenn, and
Koichi Tanaka (e.g., (51, 52)), respectively, in late 1980’s.
This is largely because of their much softer ionization
and easier practice than any other previously developed ionization techniques. Applications of these
techniques for the analysis of lipid species sequentially
occurred in literature in early 1990 as exemplified as
follows:
In 1991, Henion’s team, in collaboration with Shieh,
analyzed the standard mixtures of monoglyceride, DG,
and TG in chloroform/methanol (7:3, v/v) after direct
infusion with a Sciex TAGA 6000E triple-quadrupole
mass spectrometer (53). This represents one of the
earliest studies on neutral lipids by ESI-MS. They
made four novel findings, including i) there was
minimal in-source fragmentation; ii) the response
factors of molecular ions depended on the polarity
of the classes and on the number of double bonds;
iii) magnitude of ionization was inversely correlated to
the acyl-chain length (54); and iv) molecular ions with
sodium or ammonium adducts could be readily
formed. At a similar time, Weintraub’s group characterized the fragmentation pattern of sodiated platelet
activation factor (1-O-hexadecyl-2-acetyl-sn-glycero-3phosphocholine) by ion source-induced fragmentation
with a single quadrupole ESI mass spectrometer, which
was further validated with experiments using a triplequadrupole mass spectrometer (55).
Not long afterward, Han and Gross (56) reported
quantitative analysis of phospholipids using ESI in both
positive- and negative-ion modes and demonstrated the
profiles of phospholipids in lipid extracts from human
erythrocyte plasma membrane as sodium adducts in the
positive-ion mode and deprotonated ions in the
negative-ion mode with a Finnigan (now ThermoFisher) mass spectrometer using direct infusion. In
their studies, they recognized the impact of the dipole
in phospholipid head groups and electric field-induced
charge separation on ionization of many cellular polar
lipids. By appropriate matrix adjustments of lipid solutions (i.e., changing solution pH or ionic strength), the

selective ionization of different lipid classes and/or
categories was accomplished. This selective ionization
of lipid classes represented a de facto separation
method executed within the instrument’s ion source
and has been referred to as intrasource separation
(57–59). This concept was developed into an important
component of a shotgun lipidomics technology called
“multi-dimensional mass spectrometry-based shotgun
lipidomics (MDMS-SL)” (60, 61). This technology
enabled the accurate identification and quantification
of hundreds to thousands of individual lipid molecular
species directly from the extracts of biological samples.
Examples from the early studies include changes of
cellular lipidomes after activation of platelets (62) and
in diabetic myocardium (63).
At a similar time, LC separation coupled with ESIMS analysis was first reported by Kim et al. (64) after
their successful application of LC-thermospray MS
analysis of phospholipids (65, 66). In this first study, the
researchers exploited a C18 column to separate individual phospholipid molecular species and monitored
protonated and/or sodiated molecular ions. In the
study, they characterized the fragments from molecular ions after collision-induced dissociation (CID) in
the positive-ion mode. Furthermore, they examined
the differences of dynamic range and response factors
between lipid classes and between molecular species in
a class after optimization of experimental conditions.
The developed LC-ESI/MS method was then applied
for determining phospholipid molecular species in C-6
glioma cells after incubation with 22:6 fatty acid for
different time intervals. LC-ESI-MS/MS was soon
applied for the analysis of long chain fatty acids and
their esters (67). Characterization and quantitative
comparison of PE, lysocardiolipin, and cardiolipin
molecular species from lipid extracts from cytoplasmic membrane of bacteria offline after HPLC
separation were also conducted by ESI-MS at the
similar time (68).
At this early period, characterization of commercially
available lipid species was reported in many publications. Kerwin et al. (69) characterized major phospholipid classes including their subclass constituents, as well
as SM and ceramide molecular species in both positiveand negative-ion modes with different adducts of molecular ions after CID. Han and Gross (70) reported the
fragmentation patterns of PC, PE, and SM from sodiated and chlorinated molecular ions, and deprotonated
phosphatidic acid, PS, and cardiolipin after CID. The
group determined the ratios of fatty acyl carboxylates
yielded from sn-1 and -2 positions for discrimination of
phospholipid regioisomers and proposed potential
fragmentation mechanisms. These studies led to
develop a method for discriminating the regioisomers
of lysoPC (71). Different from these studies on characterizing broad lipid classes, deep characterization of
lipids class by class was begun in this period. For
example, Hsu and Turk started this type of research on
Retrospect and perspective of lipidomics
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sulfatide (72) and TG molecular species (73) and then
virtually on all the classes of phospholipids, sphingolipids, and glycero- and glyco-lipids, and unraveled the
fragmentation mechanisms of these classes (see the
review (74) for an example). Murphy et al. characterized
the location of double bond(s) in fatty acyl-chains of
glycerophospholipids after reaction with ozone (75) and
the fragmentation patterns of glycerophospholipids
esterified with eicosanoids (76). It should be mentioned
that MALDI-MS after postsource decay was also applied
for profiling and/or characterization of glycerophospholipid and sphingolipid fragmentation (77–79),
which was clearly served as a foundation for the applications of MALDI-MS for biological samples (80, 81).
In addition to the aforementioned intrasource separation for large scale analysis of lipids, other technologic developments for large scale lipid analysis were
successfully pursued. This includes prototypes of
shotgun lipidomics, which includes class-specific,
MDMS-SL, and a new method based on high mass accuracy/resolution spectrometry as briefed below:
In 1997, Brügger et al. (82) described the method for
profiling of different classes of glycerophospholipids
via neutral loss or precursor ion scanning of a head
group fragment specific to a class of lipids to a certain
degree. With addition of two internal standards to
correct for different ionization response factors of individual lipid species in the class, the team achieved the
quantitation of these species present in a biological
sample. This method becomes one of the shotgun lipidomics approaches (83) and has been applied for many
lipidomic studies (84–87).
In 2001, Han and Gross (54) described an approach
for quantitative analysis of individual TG analysis using
2D MS constituted with all neutral loss scans of fatty
acyls in the TG pool. In the method, the researchers
mathematically presented the different types of
correction factors for 13C isotopolog distribution at the
first time and also demonstrated the correlation of
response factor of lithiated TG molecular ions with the
total numbers of double bonds and carbon atoms in the
fatty acyl-chains of individual TG species. Unfortunately, it should be pointed out that the molecular
species-dependent ionization response factors have not
been well recognized in the lipidomics community. This
2D MS method for analysis of TG species combined
with a simulation strategy enabled scientists to identify
and quantify hundreds to thousands of individual TG
species (88). Moreover, the principles described in the
development of MDMS-SL were broadly applied in
ratiometric measurements with appropriate internal
standards (29, 57, 60, 89).
In 2002, Ekroos et al. (90) described a method for
quantitative profiling of total extracts of endogenous
phospholipids, in which simultaneous acquisition of
precursor ion spectra of multiple fragment ions using a
quadrupole time-of-flight mass spectrometer to detect
major classes of phospholipids in a single experiment. A
6
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mixture of isotopically labeled endogenous lipids was
used as comprehensive internal standards. This method
was expanded to use other strategies such as the inclusion of neutral loss scanning, data-dependent
driving, all ion fragmentation, etc. using high mass accuracy/resolution instruments such as quadrupoleorbitrap type instruments (91–94).
There were two articles published in the early period
of lipidomics development worthy to be mentioned.
The study by Koivusalo et al. (95) extensively determined the effects of fatty acyl-chain lengths and lipid
concentration on ionization response factors using a
mixture of 14 PC molecular species. They found that
response factors decreased as chain length increased,
and the increased concentrations led to marked
reduction of response factors of PC molecular species
containing longer fatty acyl-chains. Unfortunately, two
important factors regarding the processing of data
failure to correct for 13C isotopolog distribution and
lipid aggregation were not suitably considered. In
contrast, a study by Delong et al. (96) demonstrated that
LC separations resulted in variable losses of different
classes of lipids. Further, they demonstrated the
concentration-dependent linearity in the low concentration regime and the effects of CID energy on
response factors. The knowledge obtained from these
early studies greatly impacted the development of lipidomics and the broad utility of ESI-MS.
There were many studies during this early era of
lipidomics that increased the power of this technology
including large scale analyses of lipids, applications of
ESI-MS for understanding biological phenomena, and
the use of MALDI-MS with appropriate matrices for
lipid analysis. Readers interested in these studies should
find them in the literature in early review articles
published in early 2000 (58, 80, 97, 98).
The emerging of lipidomics and names of various
“types” of lipidomics
Despite the appearance of the terms “lipidome” (26),
“functional lipidomics” (27), and “lipidomic analysis”
(99) in literature before 2003, the emergence collection
of thoughts in the field was facilitated through the
use of definitive definitions in 2003 (11, 100), demonstration of the power of synergistic technologies (11, 101,
102), and the deeply penetrating power of lipidomics in
biological applications (11, 103–105). Blair et al. (101) first
demonstrated a novel technique to study eicosanoid
enantiomers and regioisomers through use of electron
capture atmospheric pressure chemical ionization-MS
after chiral chromatography and quantified molecular species using stable isotope dilution.
At a similar time, the LIPID MAPS consortium which
was led by Dr Edward A Dennis and funded by the
National Institute of Health was formed to facilitate the
development of lipidomics in multiple areas. These
included systematic classification of lipids (1), preparation of lipid standards for quantification, and

development of databases (106, 107). The aim of this
consortium was to characterize lipid metabolites and to
quantify changes in their levels and subcellular localization within a cell. This movement along with the
publication of many informative review articles around
2005 (29, 58, 108–111) greatly accelerated the growth and
development of lipidomics.
The emerging of lipidomics was well indicated with
the bloom of the books, and special issues described the
methods and applications in lipidomics in this period.
In the late years, lipidomics studies on a special category
of lipids have been frequently given a subtitle of lipidomics, such as sphingolipidomics (112–114), phospholipidomics (115, 116), mediator lipidomics (110), oxidative
lipidomics (117, 118), etc. Similarly, lipidomics applications to an area of research have also been commonly
named a subtype of lipidomics, such as neurolipidomics
(119–121), plant lipidomics (122–124), yeast lipidomics
(125, 126), dynamic lipidomics (127–129), etc. It would like
to be particularly emphasized that lipidomics is not a
sole analytical science; the determined/annotated lipid
molecular species have to follow the biological principles (130).

CURRENT STATUS OF LIPIDOMICS
Lipidomics has undergone a fundamental distinction
in the types of experiments and strategies that are
performed. One strategy, now known as targeted lipidomics seeks to identify specific metabolites that are
known to exist and alterations in their abundance. This
type of research is often hypothesis driven. A second
method, untargeted lipidomics identifies global alterations in lipid molecular species and their abundance
for both known and unknown lipids. Untargeted lipidomics is typically used for hypothesis generation
through identification of unanticipated changes in
both known and unknown lipid molecular species and
changes in their abundance. Typically, the latter is used
to develop hypotheses and new perspectives that were
not previously known. There exist some platforms
which follows in-between. For example, MDMS-SL
targets to individual lipid classes but untargets to individual molecular species of a lipid class of interest.
For targeted lipidomics, derivatization has been
widely applied taking advantage of the physical properties of the analyte and functional groups in the
targets that can easily be derivatized. For example,
charge-switch derivatization can lead up to 100-fold
increases in signal to noise ratios and be used to
confirm the initial presence of the functional group
and make a mass shift to remove target analytes from
crowded regions of the mass spectrum. Of course, with
increased sensitivity and high resolution/accurate mass
measurement, the combination of technology development and derivatization can vastly improve definitive identification and quantification of extremely low
abundance analytes for both shotgun lipidomics and

LC-MS approaches (131). In global analyses, increase in
the coverage of lipid classes and molecular species is a
key factor. The broader the coverage is, the more likely
the approach will allow dissection of entire metabolic
pathways of lipid classes/subclasses and individual
species in a system. Understanding the interrelationship between classes and species within a
metabolic pathway or connecting metabolic networks is
essential for chemical characterization. Fortunately,
multiple synergistic approaches have vastly improved
the power of identification and quantitation in the
understanding of the changes of hundreds to thousands of individual species (60, 93, 132, 133). It should be
emphasized that LIPID MAPS, now supported by the
Wellcome Trust and providing expanding databases,
educational materials, and numerous tools and software, should be the rich resources for identification
and quantification of cellular lipidomes.
In the last 20 years, development of lipidomics technologies has vastly improved by the following: i)
extensive characterization of the structures of known
lipid classes and subclasses and uncovering both new
classes and new molecular species of lipids (e.g., (4, 74,
134–138)); ii) sensitive quantification of lipid species at
attomole to femtomole levels from a variety of biological samples (e.g., (132, 139–146)); iii) applications for
biomedical and biological studies through pathway/
network analysis; iv) biomarker development that facilitates prediction, diagnosis, and prognosis of disease
states (see recent reviews for references (83, 147–156)); v)
determining the alterations of lipids in spatial distribution via mapping complex organs by MALDI imaging (see recent reviews for references (157–162)); and vi)
advances in bioinformatics to facilitate real time data
processing (e.g., (88, 163–174)).
Currently, in our view, the following areas become
the focal points in lipidomics, which largely reflects the
development of the field:
Deeply penetrating analysis of individual lipid
molecular species
As the development of lipidomics proceeded, strategies for chemical analysis of lipid metabolites have
greatly extended to identify regioisomers, stereoisomers, and diasterotopic molecular species. These
include both the use of multistage fragmentation to
identify sn-1 versus sn-2 chains, location of double
bond(s) in fatty acyl-chains, and cis-trans isomerism. To
this end, newly developed technology/instrumentation
including ultraviolet photodissociation MS (175) and a
variety of chemical reactions/derivatization approaches have been broadly used for deep analysis of
lipid molecular structures, including Paternò–Büchi
reaction (176–178) and click chemistry (179–181). Readers
interested in this area of work can find the comprehensive review of deep phenotyping with chemical reaction/derivatization approaches by Xia in this
Thematic Review series.
Retrospect and perspective of lipidomics
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Accurate quantification and standardization
As discussed in the “Introduction” section and
recognized by our group a decade ago (182), accurate
quantification of lipid species is particularly important
for lipidomics especially in confounding situations
where special attention is needed to exclude structures
with the same elemental composition. To this end, the
use of internal standards can aid accurate quantification and diagnostic derivatization in this process, as
previously discussed (183).
However, an inter-laboratory ring trial with quantification of lipids in human plasma has demonstrated
the huge variations of the quantified levels of lipid
molecular species (184), indicating the potential issues
with accurate quantification of individual lipid species.
Therefore, standardization and harmonization in an
accurate, quantitative, high throughput manner has
recently caught the attention of lipidomics community
(185–187), leading to the formation of Lipidomics
Standards Initiative Consortium and then the establishment of International Lipidomics Society. It becomes more and more clear that guidelines for the
entire workflow of lipidomic analysis, from preanalytics, lipid extractions, MS, data processing
and reporting, need to be developed and standardized.
To this end, a guideline for reporting MS-based lipidomics has recently been proposed (187). Readers
interested in this area of work could also find further
discussion by Kofeler et al. (188) in this Thematic Review series.
Clinical lipidomics
Clinical lipidomics is a new extension of lipidomics,
which aims to investigate metabolic pathways and networks through quantifying the complete spectrum of
lipidomes in cells, biopsies, and/or body fluids of patients, and to link the lipidomic components to clinical
proteomics, genomics, and phenomics to accurately diagnose human diseases (189, 190). This type of study
expands the original biomarker discovery/development using the lipidomics approach into a much
broader, clinic-related research area. This area of
research includes i) identification of molecular mechanism(s) mediating diseases for potential therapeutic
development; ii) connection of altered lipid profiles
with gene variants of patients via a genome-wide association study on selected particular genes through
which the metabolic pathways are mediated and the
network is interconnected; and iii) all types of the information from lipidomes such as the content and
composition of individual species, as well as the mass
ratios of these species for subtyping disease phenotypes
and/or subgroups of patients to serve the purpose of
precision medicine for accurate treatment; etc. (e.g.,
(191–195)). Readers interested in this area of work could
also find the comprehensive review by Meikle in this
Thematic Review series (196).

8
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Functional lipidomics
Defining the function of a class, a subclass, and individual molecular species of lipids in a cell, organ, or
organism is a long-standing task of lipid biochemistry,
which represents the definition of functional lipidomics (27). However, functional lipidomics not only
includes this type of long-standing studies but has
evolved further in studying altered lipids in specific
disease states and stages of an organism’s life cycle. As
illustrated in Fig. 3, functional lipidomics expands i)
uncovering the altered lipids between states by lipidomic analysis; ii) identifying the alterations in metabolic pathways and networks leading to the changed
lipidomes at proteome, transcriptome, and genome
levels; iii) investigating the biological/pathological
sequala of the altered lipids; and iv) developing potential therapeutics for the treatment of diseases and/or
aging based on the identified signaling, regulators, and
sequala.
Functional lipidomics was proposed at the earliest
stage of lipidomics development (27, 197, 198) and has
been caught particular attention in the field and conducted in many studies (e.g., (150, 199–203)). It is
regrettable that the majority of lipidomic studies are
still at their basic levels, i.e., profiling lipidomes, and
unable to penetrate into the interpretation of changes
in lipidomes and identification of the underlying molecular mechanism(s) leading to lipid changes. This is
largely because of the disconnect between analytical
chemists who are capable of developing lipidomic
methodology to conduct comprehensive lipidomic
analysis and those possessing broad knowledge in lipid
metabolism and having resource including animal
models to test their theories of associated biology and
the effects of drugs on the observed process.
Lipidomics of subcellular organelles
The cellular function is tightly associated with the
internal organization of cells, in which multiple subcellular compartments exist possessing specialized roles.
These organelles largely hold the secrets for normal
cellular function, progression of disease, and a plethora
of interactions among cellular molecules that define
life. Lipids play a key role in organelle functions.
Different organelles contain very different lipidomes,
which are known to vary with a circadian rhythm (204)
and patho(physio)logical conditions (10, 205). For
example, ether lipids and polyphosphoinositides play
important roles in exosomal biology (206). Therefore,
lipidomics provides detailed information of these organelles, which has the potential for insights into the
possible origin, structure, and functional alterations of
individual organelles. Fingerprinting the changes of
lipid molecular species of an organelle after a perturbation also has the power to connect changes in
organelle function with the perturbation, thereby
providing insights into molecular mechanism(s) of lipid

Fig. 3. Schematic illustration of functional lipidomics. Functional lipidomics represents a new research direction in lipidomics, in
which the altered lipids between different states are uncovered through lipidomic analysis; then the molecular mechanism(s) underpinning the changed lipids and the biological/pathological sequala of the changed lipids are identified; and finally, potential
therapeutics for treatment of diseases and/or aging based on the identified signaling, regulators, and sequala are developed.

changes and altered functions to a certain degree. Dynamic labeling of lipids in pulse chase experiments can
determine the turnover rate and flux of individual
lipid molecular species under specific perturbations,
thereby providing a real time dynamic picture of lipid
flux in individual organelles.
However, organelle lipidomics still remains as a
challenge for many scientists largely because of the
difficulty to isolate a large quantity of relatively pure
organelles. Fortunately, this issue will likely be resolved
with the development of sensitive and spatially focused
methodologies including secondary ion MS, as previously demonstrated (207). Moreover, new technologies,
robotic fluid handling systems, and spatial reconstruction methods should greatly facilitate lipidomics of
subcellular organelles. Accordingly, it can be foreseen
that lipidomics at the organelle levels will become a
part of the armamentarium of lipidomics in the near
future.

PERSPECTIVE
In the near future, the focal points at the current
lipidomics (see above) will inevitably evolve and be

solved. Moreover, the following areas of research in
lipidomics appear in demand and should be well
developed in the future. These include, but are not
limited to, i) further increases in the coverage of lipid
classes and individual species (particularly for those
very low abundance species) using an automated,
quantitative, high throughput lipidomics in combination with instrumental advances and chemical breakthroughs; ii) single cell lipidomics, as stimulated with the
fruitful development and powerful applications of
single cell genomics and demonstrated with limited
studies (208–210), will likely become a rising star; iii) MS
imaging should evolve into more quantitative and
multi-dimensional; iv) more complex dynamic studies
in metabolic flux to reveal the reaction rates in lipid
metabolism to comprehensively determine lipid metabolism in the molecular levels and provide true understanding of the roles of lipids in biomedical sciences;
and v) integration of lipidomics with other omics
considering the relationship with genes, transcripts, and
enzyme data to perform metabolic pathway reconstruction and flux analyses is in high demand, which is
still at the very early stage of development (211).
Collectively, as an interdisciplinary field, lipidomics will
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continue its exponential growth and become fully integrated with the other omics technologies and
phenotypic alterations.
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